Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_assertion type Assertion NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_head.
- NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_assertion description "[To define the difference in Grb2-associated proteins in hepatocarcinoma cells, we performed coprecipitation analysis using recombinant GST-Grb2 fusion proteins and found that several protein components (p170, p125, p100, and p80) differently associated with GST-Grb2 proteins in human Chang liver and hepatocarcinoma HepG2 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_provenance.
- NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_assertion evidence source_evidence_literature NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_provenance.
- NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_assertion SIO_000772 11746524 NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_provenance.
- NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_assertion wasDerivedFrom befree-20140225 NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_provenance.
- NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_assertion wasGeneratedBy ECO_0000203 NP167411.RAjWfe4PmKG7-kxUTEGCWH5pBtIlmeQ2vLIyfmoeHrm1c130_provenance.